Table 3.
Parameters | Category | No of cases | DSS
|
DMFS
|
LRFS
|
|||
---|---|---|---|---|---|---|---|---|
No of events | p-value | No of events | p-value | No of events | p-value | |||
Gender | Male | 95 | 45 | 0.7870 | 38 | 0.6128 | 30 | 0.3240 |
Female | 29 | 14 | 11 | 7 | ||||
Age (years) | <60 | 98 | 48 | 0.8600 | 42 | 0.3091 | 29 | 0.8206 |
≥60 | 26 | 11 | 7 | 8 | ||||
Primary tumor (T) | T1–T2 | 80 | 32 | 0.0289* | 25 | 0.0085* | 19 | 0.0180* |
T3–T4 | 44 | 27 | 24 | 18 | ||||
Nodal status (N) | N0–N1 | 56 | 18 | 0.0008* | 17 | 0.0132* | 12 | 0.0160* |
N2–N3 | 68 | 41 | 32 | 25 | ||||
Stage | I–II | 38 | 10 | 0.0020* | 9 | 0.0072* | 5 | 0.0026* |
III–IV | 86 | 49 | 40 | 32 | ||||
Histological grade | Keratinized/non-keratinized | 47 | 20 | 0.1980 | 17 | 0.2753 | 15 | 0.9521 |
Undifferentiated | 77 | 39 | 32 | 22 | ||||
Periostin | Low expression (H-score<median) | 62 | 20 | 0.0002* | 20 | 0.0138* | 13 | 0.0028* |
High expression (H-scor≥median) | 62 | 39 | 29 | 24 |
Note:
Statistically significant.
Abbreviations: DMFS, distal metastasis-free survival; DSS, disease-specific survival; LRFS, local recurrence-free survival.